UAB "Baltijos bioinovacijos" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 681,047 |
| 129,723 |
| 28,646 |
| 24,344 |
| 4,637 |
| 20.14 |
| 3.57 |
| 27,240 |
| 73,902 |
| 14,584 |
| 86,558 |
| 0.04 |
| 2.71 |
| - |
| - |
| 4.34 |
| 29,558 |
| 2023 |
|---|
| 1,322,079 |
| 173,729 |
| 104,942 |
| 89,081 |
| 11,706 |
| 27.90 |
| 6.74 |
| 116,321 |
| 114,387 |
| 91,864 |
| 138,844 |
| 0.02 |
| 0.98 |
| - |
| - |
| 8.03 |
| 106,195 |
| 2024 |
|---|
| 1,237,613 |
| 145,089 |
| 25,782 |
| 22,026 |
| 2,582 |
| 14.96 |
| 1.78 |
| 138,347 |
| 159,632 |
| 163,843 |
| 130,940 |
| 0.02 |
| 1.15 |
| - |
| - |
| 2.08 |
| 25,782 |
| 2024 |
|---|
| 1,237,613 |
| 145,089 |
| 25,782 |
| 22,026 |
| 2,582 |
| 14.96 |
| 1.78 |
| 138,347 |
| 159,632 |
| 163,843 |
| 130,940 |
| 0.02 |
| 1.15 |
| - |
| - |
| 2.08 |
| 25,782 |
Turnover (€)
2024
Turnover (€)
1,237,613 €-6 % *
Sales per employee (€)
145,089 €-16 % *
Profit before tax (€)
25,782 €-75 % *
Net Profit (€)
22,026 €-75 % *
Profit per employee (€)
2,582 €-78 % *
Total profitability (%)
14.96 %-46.38 % *
Net profitability (%)
1.78 %-73.59 % *
Equity (€)
138,347 €19 % *
Amounts Payable And Liabilities (€)
159,632 €40 % *
Non-current Assets (€)
163,843 €78 % *
CurrentAssets (€)
130,940 €-6 % *
Working capital requirement
0.02 0.00 % *
Debt-to-equity ratio
1.15 17.35 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
2.08 %-74.10 % *
EBIT (€)
25,782 €-76 % *
